Advanced search
1 file | 272.70 KB Add to list

How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions

(2019) VACCINE. 37(34). p.4805-4810
Author
Organization
Abstract
Thanks to the modern sequencing era, the extent to which infectious disease imposes selective pressures on the worldwide human population is being revealed. This is aiding our understanding of the underlying immunological and host mechanistic defenses against these pathogens, as well as potentially assisting in the development of vaccines and therapeutics to control them. As a consequence, the workshop "How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions" at the VASE 2018 meeting, aimed to discuss how genomics and related tools could be used to assist Shigella and ETEC vaccine development. The workshop featured four short presentations which highlighted how genomic applications can be used to assist in the identification of genetic patterns related to the virulence of disease, or host genetic factors that could contribute to immunity or successful vaccine responses. Following the presentations, there was an open debate with workshop attendees to discuss the best ways to utilise such genomic studies, to improve or accelerate the process of both Shigella and ETEC vaccine development. The workshop concluded by making specific recommendations on how genomic research methods could be strengthened and harmonised within the ETEC and Shigella research communities.

Downloads

  • Mottram Vaccine 2019.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 272.70 KB

Citation

Please use this url to cite or link to this publication:

MLA
Mottram, Lynda, et al. “How Genomics Can Be Used to Understand Host Susceptibility to Enteric Infection, Aiding in the Development of Vaccines and Immunotherapeutic Interventions.” VACCINE, vol. 37, no. 34, 2019, pp. 4805–10.
APA
Mottram, L., Chakraborty, S., Cox, E., & Fleckenstein, J. (2019). How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions. VACCINE, 37(34), 4805–4810.
Chicago author-date
Mottram, Lynda, Subhra Chakraborty, Eric Cox, and James Fleckenstein. 2019. “How Genomics Can Be Used to Understand Host Susceptibility to Enteric Infection, Aiding in the Development of Vaccines and Immunotherapeutic Interventions.” VACCINE 37 (34): 4805–10.
Chicago author-date (all authors)
Mottram, Lynda, Subhra Chakraborty, Eric Cox, and James Fleckenstein. 2019. “How Genomics Can Be Used to Understand Host Susceptibility to Enteric Infection, Aiding in the Development of Vaccines and Immunotherapeutic Interventions.” VACCINE 37 (34): 4805–4810.
Vancouver
1.
Mottram L, Chakraborty S, Cox E, Fleckenstein J. How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions. VACCINE. 2019;37(34):4805–10.
IEEE
[1]
L. Mottram, S. Chakraborty, E. Cox, and J. Fleckenstein, “How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions,” VACCINE, vol. 37, no. 34, pp. 4805–4810, 2019.
@article{8612086,
  abstract     = {Thanks to the modern sequencing era, the extent to which infectious disease imposes selective pressures on the worldwide human population is being revealed. This is aiding our understanding of the underlying immunological and host mechanistic defenses against these pathogens, as well as potentially assisting in the development of vaccines and therapeutics to control them. As a consequence, the workshop "How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions" at the VASE 2018 meeting, aimed to discuss how genomics and related tools could be used to assist Shigella and ETEC vaccine development. The workshop featured four short presentations which highlighted how genomic applications can be used to assist in the identification of genetic patterns related to the virulence of disease, or host genetic factors that could contribute to immunity or successful vaccine responses. Following the presentations, there was an open debate with workshop attendees to discuss the best ways to utilise such genomic studies, to improve or accelerate the process of both Shigella and ETEC vaccine development. The workshop concluded by making specific recommendations on how genomic research methods could be strengthened and harmonised within the ETEC and Shigella research communities.},
  author       = {Mottram, Lynda and Chakraborty, Subhra and Cox, Eric and Fleckenstein, James},
  issn         = {0264-410X},
  journal      = {VACCINE},
  language     = {eng},
  number       = {34},
  pages        = {4805--4810},
  title        = {How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions},
  url          = {http://dx.doi.org/10.1016/j.vaccine.2019.01.016},
  volume       = {37},
  year         = {2019},
}

Altmetric
View in Altmetric